SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-265020
Filing Date
2018-08-31
Accepted
2018-08-31 16:06:12
Documents
3
Period of Report
2018-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d614112d8k.htm 8-K 41106
2 EX-99.1 d614112dex991.htm EX-99.1 8828
3 GRAPHIC g614112g84t78.jpg GRAPHIC 2298
  Complete submission text file 0001193125-18-265020.txt   54774
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 181050189
SIC: 2834 Pharmaceutical Preparations